Altasciences Acquires Alliance Contract Pharma

Altasciences has acquired Alliance Contract Pharma. This acquisition adds small molecule contract manufacturing and analytical services from API to commercialization, including commercial manufacturing, GMP warehouse storage, and clinical supply distribution, to Altasciences’ full-service preclinical, clinical, and bioanalytical offerings.

“The addition of Alliance Contract Pharma continues to fulfill our strategy of creating a comprehensive offering that facilitates the outsourcing experience for our clients. We remain committed to providing our clients with value-added services that create a new paradigm of drug development outsourcing,” said Chris Perkin, CEO of Altasciences.

“We are excited to be joining a team that is responsive and understanding, and continuously looking to create innovative partnerships that redefine the status quo and address the challenges that our clients face in meeting critical milestones,” said Stephen Schweibenz, President of Alliance Contract Pharma.

  • <<
  • >>

Join the Discussion